Drug Pipeline

NEO100 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
1
Top Sponsors
Active Studies by Phase
Phase 2
1
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT05023018 NEO100 and High-Grade Meningioma Residual, Progressive or Recurrent Grade II or III Meningioma Recruiting
Phase 1/2
NCT02704858 Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma Glioblastoma Multiforme Recruiting
Phase 1
NCT06357377 A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain… Pediatric Tumor of CNS Not Yet Recruiting
Sponsors Running NEO100 Trials
Neonc Technologies, Inc. (3)
Disease Areas
Glioblastoma (1) Glioma (1)
Get alerts when NEO100 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free